Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Anatomía humana
7
Condiciones económicas
5
Contabilidad de costos
5
Historia
5
Política y gobierno
5
Administración de bases de datos
4
Contabilidad administrativa
4
Educación
4
Administración
3
Aspectos sociales
3
Ciclos económicos
3
Control de calidad
3
Economía
3
Estudio y enseñanza
3
Fisiología
3
Investigación
3
Sistemas operativos (Computadoras)
3
Asesinato
2
Ciencias sociales
2
Civilización
2
Construcciones de madera
2
Economía keynesiana
2
Evaluación
2
Finanzas públicas
2
Innovaciones tecnológicas
2
Investigaciones
2
Lenguaje y lenguas
2
Música para piano
2
Personal docente
2
Procesamiento de datos
2
-
5481por Dendi, Alvaro, Garcia, Ingrith Viviana Hoyos, Mejias, Asuncion, Hanlon, Cory T, Sanchez, Pablo J“…DISCLOSURES: Asuncion Mejias, MD, PhD, MsCS, Janssen (Grant/Research Support, Advisor or Review Panel member)Merck (Advisor or Review Panel member)Roche (Advisor or Review Panel member)…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5482por Ross, Jennifer K, Boeser, Kimberly D, Simonson, Dana, Hain, Malia, Killelea, Kristi, Galdys, Alison“…DISCLOSURES: Dana Simonson, PharmD, BCPS, Janssen (Advisor or Review Panel member, Other Financial or Material Support, Webinar Series Speaker Fall 2019)…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5483por Huaman, Moises A, Moussa, Anissa, Orsborn, Kris I, Ticona, Eduardo, Sanchez, Jorge, Zavaleta, Milagros, Sterling, Timothy, Chougnet, Claire, Deepe, George S, Fichtenbaum, Carl“…DISCLOSURES: Carl Fichtenbaum, MD, Amgen (Grant/Research Support, outside the submitted work)Clinical Care Options (Other Financial or Material Support, outside the submitted work)Cytodyn (Grant/Research Support, outside the submitted work)Gilead Sciences (Grant/Research Support, outside the submitted work)Janssen (Grant/Research Support, outside the submitted work)Merck (Grant/Research Support, outside the submitted work)ViiV Healthcare (Research Grant or Support, outside the submitted work)…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5484“…RESULTS: We identified 3,411 pain-related events sponsored by 3 companies: bioCSL/CSL (n = 15), Janssen (n = 134); and Mundipharma (n = 3,262). Pain-related events were most often multidisciplinary, including at least one nurse (1,964/3,411; 58%); 38% (1,281/3,411) included physicians only, and 5% (166/3,411) nurses only. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5485por Rzymski, Piotr, Zeyland, Joanna, Poniedziałek, Barbara, Małecka, Ilona, Wysocki, Jacek“…From eight vaccines unauthorized in the EU at the moment of study, the CVnCoV (mRNA; CureVac) was met with the highest level of trust, followed by Ad26.COV2.S (vector; Janssen/Johnson&Johnson) and NVX-CoV2373 (protein; Novavax). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5486por Vasireddy, Deepa, Atluri, Paavani, Malayala, Srikrishna Varun, Vanaparthy, Rachana, Mohan, Gisha“…The United States Food and Drug Administration (USFDA) has approved Pfizer-BioNTech, Moderna and Janssen coronavirus disease 2019 (COVID-19) vaccines for emergency use. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5487por Sharifian-Dorche, Maryam, Bahmanyar, Mohammad, Sharifian-Dorche, Amirhossein, Mohammadi, Pegah, Nomovi, Masood, Mowla, Ashkan“…We searched PubMed until May 19, 2021, and the following Keywords were used: COVID Vaccine & Neurology, AstraZeneca COVID vaccine, ChAdOx1 nCoV-19 COVID vaccine, AZD1222 COVID vaccine, Janssen COVID vaccine, Johnson & Johnson COVID vaccine, Ad26.COV2 COVID vaccine. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5488por Abdul-Mutakabbir, Jacinda, Casey, Samuel, Jews, Veatrice, King, Andrea, Simmons, Kelvin, Peteet, Bridgette, Belliard, Juan Carlos, Hogue, Michael, Peverini, Ricardo“…From February 1 until April 30, 2021, 24,808 individuals were vaccinated in the LLU mass clinic with a first dose (Pfizer or Moderna) or single dose (Janssen) of a COVID-19 vaccine, however, only 908 (3.7%) were Black vaccinees. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5489“…DISCLOSURES: Ahlstrom: Pfizer: Other: Patient Advisory; Janssen: Other: Patient Advisory; Takeda: Other: Patient Advisory; Bristol Myers Squibb: Other: Patient Advisory.…”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5490por Ming, Timothy, Denee, Tom, Scott, Gemma, Morrens, Joachim, Weatherburn, Christopher“…This study was sponsored by Janssen Cilag Ltd.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5491por Montano, Diego“…INTRODUCTION: This study aims to provide a risk assessment of the adverse reactions related to the COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer-BioNTech which have been in use in the European Union and the United States between December 2020 and October 2021. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5492“…Most studies (n=24) reported the use of Pfizer and Moderna COVID-19 vaccines among pregnant people; only 6 reported the Janssen vaccine. Of the 32 studies, 11 examined COVID-19 vaccine safety, 10 investigated immunogenicity and effectiveness, and 11 assessed vaccine acceptance among pregnant people. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5493por Risk, Malcolm, Shen, Chen, Hayek, Salim S, Holevinski, Lynn, Schiopu, Elena, Freed, Gary, Akin, Cem, Zhao, Lili“…BACKGROUND: There is a lack of data regarding how the Delta variant of coronavirus disease 2019 (COVID-19) has impacted the effectiveness of the BNT162b2 (Pfizer–BioNTech), mRNA-1273 (Moderna), and Ad26.COV2.S (Johnson & Johnson–Janssen) vaccines at preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 hospitalization. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5494por Gosse, L., Hacard, F., Crumbach, L., Vancappel, M., Berard, F., Nicolas, J.F., Vial, T., Juillard, L., Dussard, C., Nosbaum, A.“…Quatre d’entre eux sont actuellement disponibles en France : Comirnaty, Spikevax, Janssen, et Vaxzevria. Ils comportent comme excipients du polyethylène glycol (PEG) ou du polysorbate 80, connus comme pourvoyeurs d’anaphylaxie. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5495por Dall’Acqua, Stefano, Sut, Stefania, Zengin, Gokhan, Peron, Gregorio, Elbasan, Fevzi, Yildiztugay, Evren, Bibi Sadeer, Nabeelah, Mahomoodally, Mohamad Fawzi“…Watson, Prangos meliocarpoides var. meliocarpoides, and Prangos uechtritzii Boiss. and Hausskn. This is the first time such a report has been designed to validate the phytochemical composition and bioactivity (especially enzyme inhibitory properties) of these plants. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5496por Klett-Tammen, CJ, Heise, JK, Soja, SM, Janzen, I, Jenniches, F, Kemmling, Y, Behrens, G, Schulz, TF, Wegener, R, Castell, S“…Participants reported the following adverse events after immunization (AEFI): after 40 applied doses with Vaxzevria® 24 AEFI (60%); after 158 doses of Comirnaty® 41 AEFI (26%); after 62 doses of Spikevax® 19 AEFI (30.7%); and after three doses of Janssen®, one AEFI (33.3%). In these cohorts, 20 (23.36%) participants stated having had a SARS-CoV-2 infection, of these 16 (80%) after the last vaccination dose, three (15%) before the first dose and one (5%) in between doses. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5497por Yan, Ming-Ming, Zhao, Hui, Li, Zi-Ran, Chow, Jun-Wei, Zhang, Qian, Qi, Yu-Peng, Wu, Shu-Shan, Zhong, Ming-Kang, Qiu, Xiao-Yan“…Background and purpose: Serious adverse events following immunization (AEFI) associated with the COVID-19 vaccines, including BNT162b2 (Pfizer-BioNTech), Ad26.COV2.S (Janssen), and mRNA-1273 (Moderna), have not yet been fully investigated. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5498por Kokogho, Afoke, Aleissa, Muneerah M, Chang, Jun Bai Park, Walsh, Stephen R, Crowell, Trevor A, Baden, Lindsey R, Sherman, Amy C“…DISCLOSURES: Stephen R. Walsh, MD, Janssen Vaccines: Grant/Research Support|ModernaTX: Grant/Research Support|Sanofi Pasteur: Grant/Research Support.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5499por Swets, Maaike C, Russell, Clark, Harrison, Ewen, Docherty, Annemarie, Lone, Nazir, Girvan, Michelle, Hardwick, Hayley, Visser, Leonardus, Openshaw, Peter, Groeneveld, Geert, Semple, Calum, Baillie, Kenneth“…DISCLOSURES: Peter Openshaw, PhD, Bavarian Nordic: Advisor/Consultant|Cepheid: Advisor/Consultant|GlaxoSmithKline: Advisor/Consultant|Janssen: Advisor/Consultant|Pfizer: Advisor/Consultant Calum Semple, PhD, Integrum Scientific: Scientific Advisory Board|Integrum Scientific: Stocks/Bonds.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5500“…Main funding source(s): Janssen Pharmaceuticals…”
Enlace del recurso
Enlace del recurso
Online Artículo Texto